Cargando…
Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!
Transfection by means of non-viral gene delivery vectors is the cornerstone of modern gene delivery. Despite the resources poured into the development of ever more effective transfectants, improvement is still slow and limited. Of note, the performance of any gene delivery vector in vitro is strictl...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076396/ https://www.ncbi.nlm.nih.gov/pubmed/32098191 http://dx.doi.org/10.3390/pharmaceutics12020183 |
_version_ | 1783507206948257792 |
---|---|
author | Bono, Nina Ponti, Federica Mantovani, Diego Candiani, Gabriele |
author_facet | Bono, Nina Ponti, Federica Mantovani, Diego Candiani, Gabriele |
author_sort | Bono, Nina |
collection | PubMed |
description | Transfection by means of non-viral gene delivery vectors is the cornerstone of modern gene delivery. Despite the resources poured into the development of ever more effective transfectants, improvement is still slow and limited. Of note, the performance of any gene delivery vector in vitro is strictly dependent on several experimental conditions specific to each laboratory. The lack of standard tests has thus largely contributed to the flood of inconsistent data underpinning the reproducibility crisis. A way researchers seek to address this issue is by gauging the effectiveness of newly synthesized gene delivery vectors with respect to benchmarks of seemingly well-known behavior. However, the performance of such reference molecules is also affected by the testing conditions. This survey points to non-standardized transfection settings and limited information on variables deemed relevant in this context as the major cause of such misalignments. This review provides a catalog of conditions optimized for the gold standard and internal reference, 25 kDa polyethyleneimine, that can be profitably replicated across studies for the sake of comparison. Overall, we wish to pave the way for the implementation of standardized protocols in order to make the evaluation of the effectiveness of transfectants as unbiased as possible. |
format | Online Article Text |
id | pubmed-7076396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70763962020-03-24 Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar! Bono, Nina Ponti, Federica Mantovani, Diego Candiani, Gabriele Pharmaceutics Review Transfection by means of non-viral gene delivery vectors is the cornerstone of modern gene delivery. Despite the resources poured into the development of ever more effective transfectants, improvement is still slow and limited. Of note, the performance of any gene delivery vector in vitro is strictly dependent on several experimental conditions specific to each laboratory. The lack of standard tests has thus largely contributed to the flood of inconsistent data underpinning the reproducibility crisis. A way researchers seek to address this issue is by gauging the effectiveness of newly synthesized gene delivery vectors with respect to benchmarks of seemingly well-known behavior. However, the performance of such reference molecules is also affected by the testing conditions. This survey points to non-standardized transfection settings and limited information on variables deemed relevant in this context as the major cause of such misalignments. This review provides a catalog of conditions optimized for the gold standard and internal reference, 25 kDa polyethyleneimine, that can be profitably replicated across studies for the sake of comparison. Overall, we wish to pave the way for the implementation of standardized protocols in order to make the evaluation of the effectiveness of transfectants as unbiased as possible. MDPI 2020-02-21 /pmc/articles/PMC7076396/ /pubmed/32098191 http://dx.doi.org/10.3390/pharmaceutics12020183 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Bono, Nina Ponti, Federica Mantovani, Diego Candiani, Gabriele Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar! |
title | Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar! |
title_full | Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar! |
title_fullStr | Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar! |
title_full_unstemmed | Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar! |
title_short | Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar! |
title_sort | non-viral in vitro gene delivery: it is now time to set the bar! |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076396/ https://www.ncbi.nlm.nih.gov/pubmed/32098191 http://dx.doi.org/10.3390/pharmaceutics12020183 |
work_keys_str_mv | AT bononina nonviralinvitrogenedeliveryitisnowtimetosetthebar AT pontifederica nonviralinvitrogenedeliveryitisnowtimetosetthebar AT mantovanidiego nonviralinvitrogenedeliveryitisnowtimetosetthebar AT candianigabriele nonviralinvitrogenedeliveryitisnowtimetosetthebar |